Introduction
Studies in iatrogenic CJD are extremely useful to understand some aspects of infections in humans, as the infectious agent may reach the brain via different routes: direct inoculation (EEG depth electrodes), oral infection (growth hormone therapy, vCJD), peripheral infection (blood transfusion) and superficial infection (dura mater and corneal transplant).
■ Abstract Objective Iatrogenic Creutzfeldt-Jakob disease (iCJD) is mainly associated with dura mater (DM) grafts and administration of human growth hormones (hGH). Data on disease course in DM-CJD are limited. We describe the clinical and diagnostic findings in this patient group with special emphasis on MRI signal alterations. Methods Ten DM-CJD patients were studied for their clinical symptoms and diagnostic findings. The MRIs were evaluated for signal increase of the cortical and subcortical structures. Results DM-CJD patients had a median incubation time of 18 years and median disease duration of 7 months. The majority of patients were MM homozygous at codon 129 of the prion protein gene (PRNP) and presented with gait ataxia and psychiatric symptoms. No correlation between the graft site and the initial disease course was found. The MRI showed cortical and basal ganglia signal increase each in eight out of ten patients and thalamic hyperintensity in five out of ten cases. Of interest, patients with thalamic signal increase were homozygous for methionine. Conclusion The MRI findings in DM-CJD largely resemble those seen in sporadic CJD, as the cortex and basal ganglia are mainly affected.
■ Key words CJD · MRI · dementia · cerebellar disorder · CNS infection
The diagnosis of iCJD is based on the presence of typical symptoms (dementia, ataxia, extrapyramidal and pyramidal signs, myoclonus and akinetic mutism) and a history of iatrogenic exposure. The finding of 14-3-3 protein in the CSF may support the diagnosis (77 % sensitivity) [1, 2] . Dura mater grafts have been found as disease cause in 200 CJD patients worldwide [1] . Due to the long incubation periods ranging from 16 months to 31 years, DM-CJD cases are still detected nowadays [1, [3] [4] [5] [6] [7] [8] [9] .
Increased rates of early ataxia have been reported in DM-CJD, hGH-CJD and vCJD [10] [11] [12] [13] . In DM-CJD, a possible influence of the graft location on the clinical onset has been suggested [14, 15] . Only limited data were reported on paraclinical tests in iCJD, such as MRI. Since the MRI pattern of high signal abnormalities follows the lesion pattern of the brain as detected by pathology, the analysis of MRI in iCJD might be extremely useful.
The goals of our study were to describe MRI and clinical findings in a larger number of DM-CJD patients and to correlate them with the graft location and codon 129 genotype.
Methods
Patients with suspected CJD are reported to the CJD Surveillance Unit in Goettingen, (established in 1993) and examined by a study physician at the hospital reporting the case. A questionnaire about the patient's history (profession, habits, meat consumption) is filled out and copies are made of the medical charts (clinical findings, laboratory tests, EEG and MRI). The patients are classified as possible, probable or no CJD case according to established criteria [16] . One Croatian case (case 10) was included in this study because material was sent for genetic analysis and all clinical data were available.
■ Genetic analysis
Analysis of the prion protein gene (PRNP) was performed after isolation of genomic DNA from blood according to standard methods [17] . PRNP mutations were excluded in all but one patient by full PRNP sequencing (case 9).
■ Neuropathology
Histological examination was performed according to standard methods [18, 20] .
■ Clinical examination
The patients were examined for the presence of typical CJD symptoms at onset (within first month) and during the disease course. Symptoms representing a residual state after surgery were not included in the analysis. Residual symptoms which progressed at the time of the disease onset were considered to be CJD signs and included in the study.
■ MRI
MRIs were available in nine out of ten patients. All MR examinations had been obtained from a 1.5 Tesla scanner (a total of 11 T2w, 9 FLAIR (fluid attenuated inversion recovery), 6 PDw (proton density weighted imaging) and 4 DWI (diffusion-weighted imaging), including serial MRIs in four patients) and were mainly available as hardcopy. Digital MRI data were available in four patients (cases 2, 3, 5 and 8). The MRI scans were reported independently and in consensus by two neuroradiologists (KK and MK) aware of the CJD diagnosis but not aware of the disease aetiology. The interobserver agreement was moderate for all the sequences (Concordance 80,. and κ = 0.52) and high for FLAIR (Concordance 83.6 and κ = 0.57), PDw (Concordance 83.3 and κ = 0.67) and DWI (Concordance 83.9 and κ = 0.65). The results of the consensus review were used for the study.
Using a standardized protocol, seven cortical areas (the frontal, parietal, temporal, occipital and insula cortex, as well as the cingulate gyrus and hippocampus), the basal ganglia (caudate nucleus, putamen, globus pallidus), the thalamus and the cerebellum were assessed for signal increase in relation to suspected normointense tissue.
Results

■ Patients with dura mater grafts
In the years 1993 to 2006, ten DM-CJD cases (four definite and six probable) were identified (nine in Germany, one in Croatia) ( Table 1 ). All surgeries were performed between 1980 and 1987 ( Fig. 1) . The median age at onset was 55 years (range 25-70); the median disease duration was 8 months (range 2-30). Incubation periods ranged from 9 to 23 years (median 18 years) (Fig. 1) .
The codon 129 genotype was available in all patients (8 MM, 1 VV and 1 MV). Codon 219 was not examined in any case. The type of pathological prion protein (PrP Sc 1 or 2) was analyzed in three out of four autopsied cases (only formalin fixed brain tissue was available in one patient): Three patients displayed PrP Sc type 1. In one further case, the PrP Sc type could not be clearly identified as type one or two (case 7) (as previously discussed) [21] (Table 1) .
■ Clinical presentation
The main symptoms at onset (within the first month) and during the course of the disease are displayed in Table 2 . Seven out of ten patients presented with gait ataxia (in three cases in isolation). Psychiatric abnormalities (depression and aggression) occurred in four out of ten patients (in one case as the only presenting symptom). Visual signs (double vision) were found in three patients, pyramidal signs (hemiparesis) in two and extrapyramidal signs (rigidity and choreatic movements) in one out of ten patients.
Only one patient displayed early signs of dementia. As unspecific clinical signs, vertigo (five patients) and headaches (five patients, data not displayed) were found most frequently. Further symptoms observed in the early disease stage were dysaesthesias in three patients and loss of hearing, tinnitus, dysarthria, aphasia, abnormal sense of taste in one patient each.
■ Time course of symptoms
The median duration from the beginning of the disease to the onset of typical CJD symptoms is given in Fig. 2 . Ataxia and psychiatric signs were among the earliest symptoms and followed by visual signs (median 1 month) and dementia (median 2 months). Myoclonus, extrapayramidal and pyramidal signs were typical signs of the advanced disease stage (median 3 to 4 months). Akinetic mutism was found in only two patients.
■ Dura graft location and initial clinical symptoms
Details on the graft placement and the clinical signs are shown in Table 2 .
Early ataxia occurred most frequently in patients with suboccipital graft (four cases) but also in three patients with different graft location. Psychiatric signs were predominant in patients with frontal graft (three cases) but also found in one patient with suboccipital graft. Two patients with early pyramidal signs (hemiparesis) had a dura graft in the parietal area. Early rigidity was found in one patient with frontobasal graft. In four patients, the early disease course appeared to be monosymptomatic: three patients with suboccipital graft showed isolated ataxia for a time period of 4 weeks (case 9), 6 weeks (case 7) and 8 weeks (case 10). In one further patient with frontobasal graft, only psychiatric signs were present for a time period of 6 months (case 2).
■ MRI
A synopsis of the MRI findings and applied sequences is given in Table 3 . The cingulate gyrus was the most frequently affected cortex region (eight out of ten), followed by the frontal, temporal and parietal lobes (six out of ten, each).The occipital cortex was least affected (three out of ten). Basal ganglia hyperintensity was found in eight out of ten patients (in one case only during follow-up), and thalamic hyperintensity in five (in three cases only on PDw). In one patient (MV type), no signal abnormalities were found (Fig. 3) . The current criteria for a pulvinar-or hockey stick sign (pulvinar or dorsomedial thalamus brighter than the other grey matter) were not met in any of the patients [22, 23] . Two patients showed pronounced signal increase in the brain hemisphere containing the graft: In one patient with right temporal graft, the signal increase was more pronounced in the right temporal and parietal lobes (Case 4). In one patient with left suboccipital graft, the left frontal cortex appeared to be more hyperintense than on the right side (Case 10). In two other patients, the findings were reversed (signal more pronounced in the opposite brain hemisphere) (Cases 6 and 9).
Discussion
In a recent study on DM-CJD cases, MRI sensitivity was reported to be high but no details were given on the involved brain areas [24] . According to a literature review, basal ganglia signal increase was found in eight out of 27 patients [6, 8, 9, 21, 25, 26] , additional cortical signal increase in three [9, 25, 26] and thalamic hyperintensity in one [9] . In a large number of further cases, only atrophy was reported, which is most likely due to the less com- (Table 4) [3, 5-9, 21, 25-41].
We studied the MRI findings in ten iatrogenic CJD patients after dura mater transplant by highly sensitive sequences. Cortex involvement was found in all but two patients. The basal ganglia were affected in eight, the thalamus in five and the cerebellum in two cases. The majority of our patients was MM homozygous at codon 129 of the PRNP and presented with gait ataxia.
At first sight, the MRI findings in our patients seem to largely resemble those seen in sporadic CJD. In sCJD, six molecular types (codon 129 genotype + PrP Sc type 1 or 2; MM1, MM2, MV1, MV2, VV1, VV2) have been described with various clinical and diagnostic findings [42, 43] . Basal ganglia and cortical signal increase are most frequently found on the MRI [44] [45] [46] [47] [48] . Thalamic signal increase represents a comparatively rare finding, which seems to largely depend on the application of DW images [45] [46] [47] [48] .
Although the majority of our patients were not distinguishable from sporadic cases by means of MRI, the finding of thalamic hyperintensity in five out of eight MM homozygous patients is notable. According to previous literature reports, thalamic hyperintensity appears to be rather typical of MV2 type sporadic CJD and atypical of MM homozygous sCJD patients [49] [50] [51] . However, as only small patient groups have been studied so far with limited numbers of DW images, it remains to be confirmed that thalamic hyperintensity is rather not typical of MM homozygous sporadic CJD.
From the clinical point of view, sporadic CJD cases with MM homozygosity may present with rapidly progressive dementia (MM1 individuals), rather slowly developing cognitive signs (MM2-cortical individuals) or early ataxia (MM2-thalamic individuals with variable disease onset). The latter patients, who clinically most resemble our iatrogenic patients, are however well dis- months after onset; n.a. not applicable; * patients included in our study tinguished by MRI, as signal abnormalities are usually not observed in this particularly rare disease type. In MM2-cortical individuals, signal increase was mainly found in the cortex (Table 5 ) [7, 9, 22, 30, 31, 34, 44, [50] [51] [52] [53] [54] .
Variant CJD patients, who may also present with early psychiatric signs and gait ataxia, may be differentiated from our cases by the presence of the pulvinar sign on the MRI. In the early disease stages, this finding may however be missing and follow-up exams should thus be performed [22] . Finally, a typical history of surgery may shift the diagnosis to iatrogenic CJD rather than sporadic or variant (Table 5) [7, 9, 22, 30, 31, 34, 44, [50] [51] [52] [53] [54] .
Three of our MM homozygous patients did not show thalamic signal increase on the MRI. This might be explained by the MR examination time point and applied MR sequences, as thalamic signal changes were mainly seen in the later disease stages and on PDw images. Although the PDw sensitivity for thalamic hyperintensity has been reported to be high, it should be considered that information on the specificity of this sequence is very limited [22, 47] .
Thalamic hyperintensity has also been reported in a Japanese dura recipient (MM type), four growth hormone recipients (two MV types, one VV type and one with unknown genotype) and one case of vCJD after blood transfusion (MM type) [9, 55, 56] . In conclusion, we have to consider the possibility that thalamic hyperintensity might be a peculiarity of acquired CJD forms.
In line with other studies, our patients were mainly MM homozygous at codon 129 of the PRNP [1, 11, 12, 26] . The prevalence of MM or VV homozygosity in iCJD has been discussed as due to increased susceptibility.
Methionine and valine homozygosity are associated with shorter incubation periods in iCJD [1, [57] [58] [59] . However, in DM-CJD cases, no such influence was found [60] . Compared to other reports, the incubation periods observed in our patients were significantly prolonged (mean 18 years vs. 8 years), which may be best explained by the fact that German CJD surveillance was only first established in 1993 [11] . Iatrogenic CJD cases with shorter incubation periods were thus probably missed.
No clear correlation between the original graft location, the clinical syndrome and the MRI signal alterations was found, which may be due to varying examination time points and techniques or may indicate the independence of MRI signal alterations in iatrogenic CJD. Another possibility to discuss is that the clinical syndrome and MRI changes might be functions of the infectious agent's characteristics rather than the site of inoculation.
DM-CJD cases have recently been divided into a plaque type and non-plaque type on the basis of clinicopathological findings. The plaque type usually presents with ataxia, whereas classic CJD features are found in the non-plaque type [24] . MRI hyperintensities were frequent in both types (not described in detail). In our study group, neuropathological data were limited and only one patient with florid plaques was found. This case presented with isolated ataxia, and the MRI showed hyperintensities of the cortex, basal ganglia and thalamus.
Summarizing, the MRI findings in DM-CJD are similar to sporadic CJD, showing frequent cortex and basal ganglia involvement. Thalamic hyperintensities in MM homozygotes might however be suggestive of an iatrogenic CJD form, rather than sporadic.
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